Affinity selection mass spectrometry speeding drug discovery

被引：10
|
作者：
Prudent, Renaud [1 ]
Lemoine, Hugues [1 ]
Walsh, Jarrod [2 ]
Roche, Didier [1 ]
机构：
[1] Edelris, Bioparc,Bioserra 1 Bldg, Lyon, France
[2] AstraZeneca, R&D BioPharmaceut, Discovery Sci, High Throughput Screening,Hit Discovery, Alderley Pk, England
来源：
DRUG DISCOVERY TODAY | 2023年 / 28卷 / 11期
关键词：
af finity selection mass spectrometry; hit identi fication; drug discovery; COMBINATORIAL LIBRARIES; HIT IDENTIFICATION; LIGANDS; CHROMATOGRAPHY; TECHNOLOGIES; INHIBITORS; EVOLUTION; MAGMASS; SITE; MS;
D O I：
10.1016/j.drudis.2023.103760
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Affinity selection mass spectrometry (AS-MS) has gained momentum in drug discovery. This review summarizes how this technology has slowly risen as a new paradigm in hit identification and its potential synergy with DNA encoded library technology. It presents an overview of the recent results on challenging targets and perspectives on new areas of research, such as RNA targeting with small molecules. The versatility of the approach is illustrated and strategic drivers discussed in terms of the experience of a small-medium CRO and a big pharma organization.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] Revolution of Small Molecule Drug Discovery by Affinity Selection-Mass Spectrometry Technology
    Motoyaji, Takashi
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (03) : 191 - 193
  • [2] Affinity selection-mass spectrometry screening techniques for small molecule drug discovery
    Annis, D. Allen
    Nickbarg, Elliot
    Yang, Xianshu
    Ziebell, Michael R.
    Whitehurst, Charles E.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2007, 11 (05) : 518 - 526
  • [3] Mass spectrometry in drug discovery
    Károly Vékey
    Reaction Kinetics and Catalysis Letters, 2002, 77 (2): : 397 - 398
  • [4] Affinity selection-mass spectrometry screening: Development and validation of a 384-well ultrafiltration format for drug discovery
    Williamson, Robert
    Terry, David
    Roth, Gregory
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [5] Discovery of Selective RNA-Binding Small Molecules by Affinity Selection Mass Spectrometry
    Rizvi, Noreen F.
    Howe, John A.
    Nahvi, Ali
    Klein, Daniel J.
    Fischmann, Thierry O.
    Kim, Hai-Young
    McCoy, Mark A.
    Walker, Scott S.
    Hruza, Alan
    Richards, Matthew P.
    Chamberlin, Chad
    Saradjian, Peter
    Butko, Margaret T.
    Mercado, Gabriel
    Burchard, Julja
    Strickland, Corey
    Dandliker, Peter J.
    Smith, Graham F.
    Nickbarg, Elliott B.
    ACS CHEMICAL BIOLOGY, 2018, 13 (03) : 820 - 831
  • [6] Speeding drug discovery
    Studt, T
    R&D MAGAZINE, 1997, 39 (13): : 47 - 48
  • [7] Kinase drug discovery by affinity selection/mass spectrometry (ASMS): Application to DNA damage checkpoint kinase Chk1
    Comess, Kenneth M.
    Trumbull, Jonathan D.
    Park, Chang
    Chen, Zehan
    Judge, Russell A.
    Voorbach, Martin J.
    Coen, Michael
    Gao, Lan
    Tang, Hua
    Kovar, Peter
    Cheng, Xueheng
    Schurdak, Mark E.
    Zhang, Haiying
    Sowin, Tom
    Burns, David J.
    JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (07) : 755 - 764
  • [8] Strategic use of affinity-based mass spectrometry techniques in the drug discovery process
    Kelly, MA
    McLellan, TJ
    Rosner, PJ
    ANALYTICAL CHEMISTRY, 2002, 74 (01) : 1 - 9
  • [9] Mass spectrometry in drug discovery and development
    Michnowicz, J
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (08) : 651 - 651
  • [10] Mass spectrometry in drug discovery and development
    John Michnowicz
    Nature Reviews Drug Discovery, 2002, 1 : 651 - 651
12345